Results 211 to 220 of about 1,825,012 (307)

Gestational and postpartum maternal consequences of gestational diabetes mellitus. [PDF]

Front Endocrinol (Lausanne)
Wu CK, Chang CY, Seow KM, Huang YC, Chuang CW, Chen M.   +5 more
europepmc   +1 more source

DIABETES MELLITUS

American Journal of Public Health, 1924
openaire   +3 more sources

Prescribing competence: The pros and cons of different methods for assessment

British Journal of Clinical Pharmacology, EarlyView.
Evaluating a medical graduate’s competence in rational prescribing is challenging. With the aim to guide and inspire teachers, this narrative review explores different methods that can be used to assess prescribing competence. Each method has its own advantages and disadvantages, and thus a mix of different assessment methods is needed throughout the ...
David J. Brinkman, Erik M. Donker, Jelle Tichelaar, on behalf of the CP4T programme   +3 more
wiley   +1 more source

Novel Therapeutic Strategies for Patients With CKD and Diabetes Mellitus. [PDF]

Kidney Int Rep
Kugathasan L, Katz A, Muskiet MHA, Sridhar VS, Scott J, Yi TW, Cherney DZI.   +6 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Guides to aurthors

Сахарный диабет, 2009
Editorial team Diabetes Mellitus
doaj   +1 more source

Mapping the research landscape on diabetes mellitus and periodontal disease: a scientometric study. [PDF]

Saudi Dent J
Repanovici A, Vîlcu ME, Pantea I.
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Reply: Detrimental effects of diabetes mellitus in alcoholic liver disease. [PDF]

Hepatol Commun
Ward B, Parker R.
europepmc   +1 more source